• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌 PPE18 蛋白抑制小鼠 MHC Ⅱ类抗原呈递和 B 细胞反应。

Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice.

机构信息

Laboratory of Molecular Cell Biology, Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India.

Graduate Studies, Manipal Academy of Higher Education, Manipal, India.

出版信息

Eur J Immunol. 2021 Mar;51(3):603-619. doi: 10.1002/eji.201848071. Epub 2020 Dec 1.

DOI:10.1002/eji.201848071
PMID:33084017
Abstract

PPE18 protein belongs to PE/PPE family of Mycobacterium tuberculosis. We reported earlier that PPE18 protein provides survival advantage to M. tuberculosis during infection. In the current study, we found that PPE18 inhibits MHC class II-mediated antigen presentation by macrophages in a dose-dependent manner without affecting the surface level of MHC class II or co-stimulatory molecules. PPE18 does not affect antigen uptake or presentation of preprocessed peptide by macrophages. Antigen degradation was found to be inhibited by PPE18 protein due to perturbation in phagolysosomal acidification. PPE18-mediated inhibition of MHC class II antigen presentation caused poorer activation of CD4 T cells. Mice infected with M. smegmatis expressing PPE18 exhibited reduced maturation and activation of B cells and had decreased Mycobacteria-specific antibody titers. Thus M. tuberculosis probably utilizes PPE18 to inhibit MHC class II antigen presentation causing poorer activation of adaptive immune responses. This study may be useful in understanding host-pathogen interaction and open up directions of designing novel therapeutics targeting PPE18 to tackle this nefarious pathogen.

摘要

PPE18 蛋白属于结核分枝杆菌的 PE/PPE 家族。我们之前曾报道过,PPE18 蛋白在感染期间为结核分枝杆菌提供生存优势。在本研究中,我们发现 PPE18 以剂量依赖的方式抑制巨噬细胞中 MHC Ⅱ类介导的抗原呈递,而不影响 MHC Ⅱ类或共刺激分子的表面水平。PPE18 不影响抗原摄取或巨噬细胞预处理肽的呈递。由于吞噬体酸化受到干扰,发现抗原降解被 PPE18 蛋白抑制。PPE18 介导的 MHC Ⅱ类抗原呈递抑制导致 CD4 T 细胞的激活较差。感染表达 PPE18 的耻垢分枝杆菌的小鼠表现出 B 细胞成熟和激活减少,并且针对分枝杆菌特异性抗体滴度降低。因此,结核分枝杆菌可能利用 PPE18 抑制 MHC Ⅱ类抗原呈递,从而导致适应性免疫反应的激活较差。这项研究可能有助于理解宿主-病原体相互作用,并为设计针对 PPE18 的新型治疗方法以应对这种有害病原体开辟方向。

相似文献

1
Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice.结核分枝杆菌 PPE18 蛋白抑制小鼠 MHC Ⅱ类抗原呈递和 B 细胞反应。
Eur J Immunol. 2021 Mar;51(3):603-619. doi: 10.1002/eji.201848071. Epub 2020 Dec 1.
2
Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.Toll样受体信号传导病原体相关分子模式可抑制交替性I类主要组织相容性复合体抗原加工:结核分枝杆菌19 kDa脂蛋白、CpG DNA和脂多糖。
J Immunol. 2003 Aug 1;171(3):1413-22. doi: 10.4049/jimmunol.171.3.1413.
3
The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage.结核分枝杆菌的PPE18与Toll样受体2相互作用并激活巨噬细胞中白细胞介素10的诱导。
J Immunol. 2009 Nov 15;183(10):6269-81. doi: 10.4049/jimmunol.0901367. Epub 2009 Oct 30.
4
Recombinant Lipoprotein Rv1016c Derived from Is a TLR-2 Ligand that Induces Macrophages Apoptosis and Inhibits MHC II Antigen Processing.源自结核分枝杆菌的重组脂蛋白Rv1016c是一种TLR-2配体,可诱导巨噬细胞凋亡并抑制MHC II抗原加工。
Front Cell Infect Microbiol. 2016 Nov 18;6:147. doi: 10.3389/fcimb.2016.00147. eCollection 2016.
5
Suppression of autophagy and antigen presentation by Mycobacterium tuberculosis PE_PGRS47.结核分枝杆菌 PE_PGRS47 对自噬和抗原呈递的抑制作用。
Nat Microbiol. 2016 Aug 15;1(9):16133. doi: 10.1038/nmicrobiol.2016.133.
6
The PPE18 protein of Mycobacterium tuberculosis inhibits NF-κB/rel-mediated proinflammatory cytokine production by upregulating and phosphorylating suppressor of cytokine signaling 3 protein.结核分枝杆菌 PPE18 蛋白通过上调和磷酸化细胞因子信号转导抑制蛋白 3 来抑制 NF-κB/rel 介导的促炎细胞因子产生。
J Immunol. 2011 May 1;186(9):5413-24. doi: 10.4049/jimmunol.1000773. Epub 2011 Mar 30.
7
PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2-dependent maturation of dendritic cells.PPE60 抗原通过 Toll 样受体 2 依赖性树突状细胞成熟驱动 Th1/Th17 反应。
J Biol Chem. 2018 Jun 29;293(26):10287-10302. doi: 10.1074/jbc.RA118.001696. Epub 2018 May 8.
8
Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.结核分枝杆菌19-kDa脂蛋白通过Toll样受体2依赖性抑制巨噬细胞II类主要组织相容性复合体表达及抗原加工
J Immunol. 2001 Jul 15;167(2):910-8. doi: 10.4049/jimmunol.167.2.910.
9
Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.抗原呈递欠佳促成结核分枝杆菌在体内的毒力。
J Immunol. 2016 Jan 1;196(1):357-64. doi: 10.4049/jimmunol.1501494. Epub 2015 Nov 16.
10
Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages.结核分枝杆菌抑制小鼠骨髓巨噬细胞中MHC II类抗原的加工处理。
Cell Immunol. 2000 Apr 10;201(1):63-74. doi: 10.1006/cimm.2000.1633.

引用本文的文献

1
PPE18 Protein Bodies in Insect Cells: A Candidate Tuberculosis Vaccine.昆虫细胞中的PPE18蛋白体:一种潜在的结核病疫苗。
Vaccines (Basel). 2025 Jun 23;13(7):671. doi: 10.3390/vaccines13070671.
2
Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design.发现并填补T细胞介导的结核病免疫机制中的知识空白,为疫苗设计提供依据。
Nat Rev Immunol. 2025 Jun 13. doi: 10.1038/s41577-025-01192-z.
3
New Advances in the Development and Design of Vaccines: Construction and Validation of Multi-Epitope Vaccines for Tuberculosis Prevention.
疫苗研发与设计的新进展:用于预防结核病的多表位疫苗的构建与验证
Biology (Basel). 2025 Apr 13;14(4):417. doi: 10.3390/biology14040417.
4
Development of a Vaccine Candidate Based on Surface-Displayed Particles of from the MTB39A Protein.基于结核分枝杆菌39A蛋白表面展示颗粒的候选疫苗的研发。
Int J Mol Sci. 2025 Jan 18;26(2):797. doi: 10.3390/ijms26020797.
5
Tuberculosis vaccines and therapeutic drug: challenges and future directions.结核病疫苗与治疗药物:挑战与未来方向
Mol Biomed. 2025 Jan 22;6(1):4. doi: 10.1186/s43556-024-00243-6.
6
Advancing Roles and Therapeutic Potentials of Pyroptosis in Host Immune Defenses against Tuberculosis.焦亡在宿主抗结核免疫防御中的作用及治疗潜力的研究进展
Biomolecules. 2024 Oct 4;14(10):1255. doi: 10.3390/biom14101255.
7
Optimizing antigen selection for the development of tuberculosis vaccines.优化用于结核病疫苗研发的抗原选择。
Cell Insight. 2024 Mar 16;3(3):100163. doi: 10.1016/j.cellin.2024.100163. eCollection 2024 Jun.
8
Immunological effects of the PE/PPE family proteins of and related vaccines.及相关疫苗的 PE/PPE 家族蛋白的免疫效应。
Front Immunol. 2023 Sep 27;14:1255920. doi: 10.3389/fimmu.2023.1255920. eCollection 2023.
9
Establishment of an indirect ELISA for Mycobacterium tuberculosis MTB39A protein antibody.用于结核分枝杆菌MTB39A蛋白抗体的间接酶联免疫吸附测定法的建立。
Appl Microbiol Biotechnol. 2023 Oct;107(20):6339-6349. doi: 10.1007/s00253-023-12715-w. Epub 2023 Aug 19.
10
Insight into pathogenomics and phylogeography of hypervirulent and highly-lethal Mycobacterium tuberculosis strain cluster.深入了解高毒力、高致死性结核分枝杆菌株群的病原体组学和系统地理学。
BMC Infect Dis. 2023 Jun 23;23(1):426. doi: 10.1186/s12879-023-08413-7.